Amyloid Triggers Extensive Cerebral Angiogenesis Causing Blood Brain Barrier Permeability and Hypervascularity in Alzheimer's Disease
暂无分享,去创建一个
[1] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[2] H. Vinters. Cerebral amyloid angiopathy. A critical review. , 1987, Stroke.
[3] J. Folkman,et al. Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.
[4] L. Thal,et al. Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension. , 1995, Archives of neurology.
[5] S. Younkin,et al. Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice , 1996, Science.
[6] M. Verbeek,et al. The role of amyloid in the pathogenesis of Alzheimer's disease. , 1997, Biological chemistry.
[7] D L Price,et al. Alzheimer's disease: genetic studies and transgenic models. , 1998, Annual review of genetics.
[8] Yu-Min Kuo,et al. Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. , 1998, The American journal of pathology.
[9] A. Hofman,et al. Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study , 1998, The Lancet.
[10] A. Giatromanolaki,et al. Intratumoral angiogenesis: a new prognostic indicator for stage I endometrial adenocarcinomas? , 1999, Oncology research.
[11] A Hofman,et al. Diabetes mellitus and the risk of dementia , 1999, Neurology.
[12] D. Small,et al. Regulation of APP cleavage by α‐, β‐ and γ‐secretases , 2000 .
[13] R. A. Frommelt,et al. Cerebral Beta Amyloid Angiopathy Is a Risk Factor for Cerebral Ischemic Infarction. A Case Control Study in Human Brain Biopsies , 2000, Journal of neuropathology and experimental neurology.
[14] B Frangione,et al. Substitutions at codon 22 of Alzheimer's abeta peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells. , 2000, The Journal of biological chemistry.
[15] D. Small,et al. Regulation of APP cleavage by alpha-, beta- and gamma-secretases. , 2000, FEBS letters.
[16] L. Martinian,et al. Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementia. , 2001, The American journal of pathology.
[17] J Tuomilehto,et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study , 2001, BMJ.
[18] Abnormal endothelial tight junctions in active lesions and normal-appearing white matter in multiple sclerosis. , 2002, Brain pathology.
[19] Anders Wallin,et al. Increased intrathecal levels of the angiogenic factors VEGF and TGF-β in Alzheimer’s disease and vascular dementia , 2002, Neurobiology of Aging.
[20] Shant Kumar,et al. CD105 is important for angiogenesis: evidence and potential applications , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[21] D. Dickstein,et al. Blood—Brain Barrier Permeability Precedes Senile Plaque Formation in an Alzheimer Disease Model , 2003 .
[22] R. Malinow,et al. APP Processing and Synaptic Function , 2003, Neuron.
[23] M. Hayden,et al. Efflux and Atherosclerosis: The Clinical and Biochemical Impact of Variations in the ABCA1 Gene , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[24] J. Silverman,et al. Endoglin (CD105) Expression in Endometrial Carcinoma , 2003, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[25] Ann Marie Schmidt,et al. RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain , 2003, Nature Medicine.
[26] R. Deane,et al. LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. , 2004, Neuron.
[27] J. Silverman,et al. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancer , 2004, Modern Pathology.
[28] J. Esteban. Living with the enemy: a physiological role for the beta-amyloid peptide. , 2004, Trends in neurosciences.
[29] Jonathan Charles Goddard,et al. A computer image analysis system for microvessel density measurement in solid tumours , 2004, Angiogenesis.
[30] W. Lukiw,et al. Angiogenic signaling in Alzheimer's disease , 2004, Neuroreport.
[31] H. Vinters,et al. Stroke related to cerebral amyloid angiopathy: the significance of systemic vascular disease , 1989, Journal of Neurology.
[32] R. Mrak,et al. Microglia and neuroinflammation: a pathological perspective , 2004 .
[33] S. Lo,et al. Quantitative analysis of angiogenesis using confocal laser scanning microscopy , 2004, Angiogenesis.
[34] N. Patel,et al. Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis , 2004, Neuroscience Letters.
[35] J. Esteban,et al. Living with the enemy: a physiological role for the β-amyloid peptide , 2004, Trends in Neurosciences.
[36] Peter J. Lenting,et al. LRP/Amyloid β-Peptide Interaction Mediates Differential Brain Efflux of Aβ Isoforms , 2004, Neuron.
[37] John Hardy,et al. Dense-core plaques in Tg2576 and PSAPP mouse models of Alzheimer's disease are centered on vessel walls. , 2005, The American journal of pathology.
[38] Hilkka Soininen,et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. , 2005, Archives of neurology.
[39] V. Mathura,et al. Anti-angiogenic activity of the mutant Dutch A(beta) peptide on human brain microvascular endothelial cells. , 2005, Brain research. Molecular brain research.
[40] C. Peers,et al. Physiological roles for amyloid β peptides , 2006 .
[41] Michela Gallagher,et al. A specific amyloid-beta protein assembly in the brain impairs memory. , 2006, Nature.
[42] Mathias Jucker,et al. Mechanism of Cerebral β‐Amyloid Angiopathy: Murine and Cellular Models , 2006 .
[43] C. Peers,et al. Physiological roles for amyloid beta peptides. , 2006, The Journal of physiology.
[44] S. Skaper,et al. Amyloid beta-peptide1-42 alters tight junction protein distribution and expression in brain microvessel endothelial cells. , 2006, Neuroscience letters.
[45] A. Drzezga,et al. In vivo characterization of endothelial cell activation in a transgenic mouse model of Alzheimer’s disease , 2006, Angiogenesis.
[46] S. Skaper,et al. Amyloid β-peptide1–42 alters tight junction protein distribution and expression in brain microvessel endothelial cells , 2006, Neuroscience Letters.
[47] M. Gallagher,et al. A specific amyloid-β protein assembly in the brain impairs memory , 2006, Nature.
[48] J. Hardy,et al. Has the amyloid cascade hypothesis for Alzheimer's disease been proved? , 2006, Current Alzheimer research.
[49] Kaan E. Biron,et al. Aβ peptide immunization restores blood‐brain barrier integrity in Alzheimer disease , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[50] K. Jellinger,et al. The enigma of vascular cognitive disorder and vascular dementia , 2007, Acta Neuropathologica.
[51] Mathias Jucker,et al. Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models. , 2006, Brain pathology.
[52] C. Grandi,et al. Beta amyloid angiogenic activity in vitro and in vivo. , 2007, International journal of molecular medicine.
[53] Jeffrey K. Cohen,et al. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in prostatic adenocarcinoma. , 2007, American journal of clinical pathology.
[54] Xiongwei Zhu,et al. Vascular oxidative stress in Alzheimer disease , 2007, Journal of the Neurological Sciences.
[55] J. Melchor,et al. Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease. , 2007 .
[56] A. Palmeri,et al. Picomolar Amyloid-β Positively Modulates Synaptic Plasticity and Memory in Hippocampus , 2008, The Journal of Neuroscience.
[57] Epsilon-secretase: reduction of amyloid precursor protein epsilon-site cleavage in Alzheimer's disease. , 2008, Current Alzheimer research.
[58] J. Kotarek,et al. Soluble aggregates of the amyloid‐β protein selectively stimulate permeability in human brain microvascular endothelial monolayers , 2008, Journal of neurochemistry.
[59] Tsuyoshi Miyakawa,et al. Dissection of Hippocampal Dentate Gyrus from Adult Mouse , 2009, Journal of visualized experiments : JoVE.
[60] Joanna M. Wardlaw,et al. Blood–brain barrier: Ageing and microvascular disease – systematic review and meta-analysis , 2009, Neurobiology of Aging.
[61] V. Natarajan,et al. Vascular endothelial barrier dysfunction mediated by amyloid-beta proteins. , 2009, Journal of Alzheimer's disease : JAD.
[62] P. Carvey,et al. Evidence of angiogenic vessels in Alzheimer’s disease , 2009, Journal of Neural Transmission.
[63] Reinhard Schliebs,et al. Vascular endothelial growth factor (VEGF) affects processing of amyloid precursor protein and β-amyloidogenesis in brain slice cultures derived from transgenic Tg2576 mouse brain , 2009, International Journal of Developmental Neuroscience.
[64] S. Donnini,et al. Dutch and Arctic mutant peptides of beta amyloid(1-40) differentially affect the FGF-2 pathway in brain endothelium. , 2009, Experimental cell research.
[65] M. Shibuya. Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor , 2009, The FEBS journal.
[66] S. Moochhala,et al. Involvement of ROS in BBB dysfunction , 2009, Free radical research.
[67] J. Newcombe,et al. Increased blood vessel density and endothelial cell proliferation in multiple sclerosis cerebral white matter , 2010, Neuroscience Letters.
[68] P. Mcgeer,et al. Converging perturbed microvasculature and microglial clusters characterize Alzheimer disease brain. , 2010, Current Alzheimer research.
[69] Berislav V. Zlokovic,et al. Pericytes Control Key Neurovascular Functions and Neuronal Phenotype in the Adult Brain and during Brain Aging , 2010, Neuron.
[70] C. Masters,et al. Iron-Export Ferroxidase Activity of β-Amyloid Precursor Protein Is Inhibited by Zinc in Alzheimer's Disease , 2010, Cell.
[71] Patrick R Hof,et al. Role of vascular risk factors and vascular dysfunction in Alzheimer's disease. , 2010, The Mount Sinai journal of medicine, New York.
[72] B. Zlokovic,et al. Neurodegeneration and the neurovascular unit , 2010, Nature Medicine.
[73] P. Couraud,et al. Differential activation of mitochondrial apoptotic pathways by vasculotropic amyloid‐β variants in cells composing the cerebral vessel walls , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[74] M. Aksenova,et al. Endogenous amyloidogenesis in long-term rat hippocampal cell cultures , 2011, BMC Neuroscience.
[75] David J. Begley,et al. Structure and function of the blood–brain barrier , 2010, Neurobiology of Disease.
[76] P. Eikelenboom,et al. Characteristics of Dyshoric Capillary Cerebral Amyloid Angiopathy , 2010, Journal of neuropathology and experimental neurology.
[77] T. Zako,et al. Amyloid oligomers: formation and toxicity of Aβ oligomers , 2010, The FEBS journal.
[78] Berislav V. Zlokovic,et al. New therapeutic targets in the neurovascular pathway in Alzheimer’s disease , 2008, Neurotherapeutics.